3 ms·
> Without that, we risk losing all of the progress we’ve made flattening the curve. I personally believe that the worst could be done in many places. New York
by mlyle 7y ago
> Without that, we risk losing all of the progress we’ve made flattening the curve.
I personally believe that the worst could be done in many places.
New York was too slow to institute controls and stopped just short of catastrophe. But, it's likely (based on extrapolation from serological data elsewhere), that 15% of people in NYC are immune and 20% will be soon. A disease with an Rt of, say, 1.8 is still scary and still requires controls and distancing, but it's a whole different ballgames from one with an Rt of 2.5. (-0.5 Rt for reduced susceptibility, -0.2 Rt for seasonal effects, say).
> There are also a growing number of experts saying that we’ll be in flux for the rest of 2020 unless we establish that survivors can’t be reinfected, which hasn’t been confirmed yet.
The case reports we have and clinical experience suggest reinfection is very rare. The bigger question is lasting immunity. Will most people be totally protected for 3 years like with a typical cold coronavirus? Or can we expect more like the 5+ years seen with SARS-CoV-1? And even if people become susceptible again, will the disease be less severe?
I also believe that in the long run, 2019-nCoV will become "just another" endemic common cold virus, and will kill small numbers of people every year just like the other endemic respiratory coronaviruses (229E, OC43 etc) do. I bet those would be pretty fearsome introduced into an immunologically naive population. Which really sucks-- say, 10% more severe respiratory illness forever is not good. But I think it's the path we're on unless we get a truly terrific vaccine, and I don't think we can bet on that.
- the_mitsuhiko 7y agoThere is no way that 15% of NY had the virus.
- mlyle 7y agoI said 15% of New York City, and now we have the data -- no preprint yet, but... https://www.npr.org/sections/coronavirus-live-updates/2020/04/23/842818125/coronavirus-has-infected-a-fifth-of-new-york-city-testing-suggests https://www.npr.org/sections/coronavirus-live-updates/2020/0...
- therealcamino 7y agoOne recent report: Two hospitals in NYC did universal screening of 215 pregnant women admitted for delivery between March 22 and April 4th. 15.4% tested positive. Most of those testing positive (87.9%) had no symptoms at the time they were admitted. https://www.nejm.org/doi/full/10.1056/NEJMc2009316 https://www.nejm.org/doi/full/10.1056/NEJMc2009316
- yread 7y agoPregnant women go to hospitals for the antenatal appointments a lot though. And hospitals are full of the virus. You would expect pregnant women to be more likely to be infected than general population
- therealcamino 7y agoWithout other data I'm not sure I find that convincing. In the US, a lot of obstetrical care takes place at offices away from hospitals.
- mlyle 7y agoLess so in NYC, but I agree. In any case, I think the interesting things are: A) the share of infected people who will never have symptoms, and B) the share of infected people that have minor symptoms and will not be diagnosed. There's reason to believe that both A and B are significant. If they reach 90%-- which there's reason to believe they likely do-- it means that with a 1.5% cumulative case count you have more like 15% of the population having been exposed.
- mlyle 7y agoNYC's case count is 111k and we know it's very low even vs. symptomatic people. The population is 8.4 million people. This is 1.3%. Serological data from a random sample of the German town of Gangelt shows that even a robust testing regime missed about 90% of the cases. The known per-capita case count at the time of the study was similar to New York City's, but 14% of the sample carried antibodies to COVID-19. The German testing regime is and has been considerably better than what's been in NYC. I'm inclined to think that an even bigger multiple of the known case count may have been exposed in NYC than in Gangelt. Separately, Iceland keeps their test data in two bins; one for people with a known exposure history and any (even minor) symptoms, and one for members of the general population without a known exposure history or symptoms. Analysis of this data suggests about 50% of people never develop symptoms and don't have any known exposure history, in an area with a much more robust testing regime.
- the_mitsuhiko 7y ago> Serological data from a random sample of the German town of Gangelt shows that even a robust testing regime missed about 90% of the cases. The results are disputed to say the least. A random sampling study in Austria found that the true number of infected is likely to be only three times higher. > Analysis of this data suggests about 50% of people never develop symptoms At the time of the test asymptotic. They did not say never develop symptoms.
- mlyle 7y agoThe odds ratio approach was backwards-looking, so it means "never developed symptoms [in a couple of weeks]". Seems Iceland is testing a lot more than NYC and that their focused testing (which is still broader than NYC's overall testing) misses ~90% of cases. Note that the Austrian study I've read shows that current infection as detected by RT-PCR is about 3x higher than present case count, which isn't quite the same thing I'm talking about with the antibody tests in Germany. If you're referring to something else, please share. In particular, no one knows the sensitivity for RT-PCR of asymptomatic people and it might be rather low--- it's not exactly wonderful in people who are quite sick and presumably shedding more virus. I'm hoping in the next week or so we have antibody data from a couple of US jurisdictions, including the SF Bay Area. It can really inform policy.
- therealcamino 7y agoThanks for your post. Every news story seems to say "12 to 18 months for a vaccine" as if it's a given, and I always think of all the diseases for which we don't have any vaccine despite many years of effort. I don't have any background in that but I'm hoping we can see some more clear-eyed discussion of the likelihood of that.